Science
Mechanism of Action
This extract functions by inhibiting phosphodiesterase 4 (PDE4) activity and suppressing inflammatory signaling pathways induced by lipopolysaccharides (LPS) in cultured cells. It also demonstrably reduces LPS-stimulated production of reactive oxygen species (ROS) and nitric oxide (NO) within RAW 264.7 macrophages. The presence of compounds such as rutin is believed to contribute significantly to these observed antioxidant and anti-inflammatory effects.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Effectively inhibited phosphodiesterase 4 activity and suppressed lipopolysaccharide-induced inflammatory signaling.
- 02 Significantly reduced inflammatory responses within lung tissue and decreased serum immunoglobulin E levels.
- 03 Attenuated lipid accumulation, inflammation, and fibrosis, exhibiting hepatoprotective benefits.
Transparency
Dusting Analysis
No specific optimal topical concentration for human skin has been established in the provided data, precluding an assessment of potential dusting practices.
The Formula
Formulation
Stability
Specific optimal pH ranges and detailed stability characteristics are not documented in the provided research data.
Safety
Safety Profile
No comprehensive safety assessments from major regulatory bodies such as CIR, SCCS, or FDA are available for this ingredient. While The Good Scents Company indicates 'None found' for GHS classification, specific human sensitization or long-term dermal toxicity data are not detailed.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Distylium Racemosum Twig Extract presents as a valuable ingredient due to its demonstrated anti-inflammatory and antioxidant properties in robust in vitro and animal models, making it suitable for various skin types; however, further human topical efficacy data would enhance its precision application profile.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources